Chemotherapy for Bladder Cancer: Treatment Guidelines for Neoadjuvant Chemotherapy, Bladder Preservation, Adjuvant Chemotherapy, and Metastatic Cancer
- 1 January 2007
- Vol. 69 (1) , 62-79
- https://doi.org/10.1016/j.urology.2006.10.041
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-AnalysisJournal of Urology, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Primary Cisplatin, Methotrexate and Vinblastine Chemotherapy With Selective Bladder Preservation for Muscle Invasive Carcinoma of the Bladder: Long-Term Followup of a Prospective StudyJournal of Urology, 2002
- Altered fractionation in chemo-radiation for bladder cancerEuropean Journal Of Cancer, 2001
- Biological selection for organ conservationEuropean Journal Of Cancer, 2001
- A feasibility study of carboplatin with fixed dose of gemcitabine in ‘unfit’ patients with advanced bladder cancerEuropean Journal Of Cancer, 2001
- PHASE II STUDY OF PACLITAXEL AND CISPLATIN FOR ADVANCED UROTHELIAL CANCERJournal of Urology, 2000
- Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tractCancer, 2000
- Radical transurethral resection and chemotherapy inBJU International, 1999